ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 98 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,227 | -0.9% | 21,753 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,358 | -53.5% | 21,753 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $33,000 | +50.0% | 21,753 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $22,000 | -29.0% | 21,753 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $31,000 | -72.8% | 21,753 | 0.0% | 0.00% | -75.0% |
| Q4 2021 | $114,000 | -10.2% | 21,753 | 0.0% | 0.02% | -20.0% |
| Q3 2021 | $127,000 | -27.4% | 21,753 | 0.0% | 0.02% | -28.6% |
| Q2 2021 | $175,000 | -3.3% | 21,753 | 0.0% | 0.03% | -6.7% |
| Q1 2021 | $181,000 | +9.0% | 21,753 | -0.9% | 0.03% | -23.1% |
| Q4 2020 | $166,000 | -29.1% | 21,948 | 0.0% | 0.04% | -45.8% |
| Q3 2020 | $234,000 | -29.7% | 21,948 | 0.0% | 0.07% | -29.4% |
| Q2 2020 | $333,000 | +82.0% | 21,948 | 0.0% | 0.10% | +43.7% |
| Q1 2020 | $183,000 | -51.7% | 21,948 | -2.2% | 0.07% | -50.0% |
| Q4 2019 | $379,000 | – | 22,448 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
| CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |